Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia

Monitoring measurable residual disease (MRD) in acute myeloid leukemia (AML) plays an important role in predicting relapse and outcome. The applicability of the leukemia-initiating nucleophosmin1 (NPM1) gene mutations in MRD detection is well-established, while that of isocitrate dehydrogenase1/2 (I...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Kövy, Petra, Őrfi, Zoltán, Bors, András, Kozma, András, Gopcsa, László, Dolgos, János, Lovas, Nóra, Harasztdombi, József, Lakatos, Viktor, Király, Ágnes, Mikala, Gábor, Vályi-Nagy, István, Reményi, Péter, Andrikovics, Hajnalka
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2021
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216517/
https://ncbi.nlm.nih.gov/pubmed/34153064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0253386
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki